Sultan Mahmood BSc MBA

Experience

• 

  Pfizer

  Feb 1993 - Nov 2006

  Cardiac / Diabetes Care Specialist

  Hospital Specialist Representative / Primary Care Representative o Leveraged my exceptional regional market access and skills to launch an asset in a crowded market with weak evidence and yet developed it into £8 million annual sales, 52% Market share and growth of 40% per annum o Cultivated clinical and commissioning leads to launch drug and device Exubera, and Inspra in a territory which included 10 PCTs and eight NHS Trusts (four – Teaching)o Motivated and coached the team to achieve exceptional sales against targets, sales calls, meetings and effective budget utilisation. Show less

• 

  Ifonetelecom Ltd

  Jan 2007 - Apr 2007

  Sales and Marketing Manager

  o Commercial support to move business customers from standard lines to VOIP services.

• 

  Eli Lilly

  Jun 2007 - Jul 2008

  Hospital Specialist

  o Protected and grew sales of antipsychotic Zyprexa brand to £500K per month o Generated £30K per month sales of antidepressant Cymbalta

• 

  Medtronic Spine & Biologics

  Jul 2008 - Aug 2010

  Customer Relationship Manager

  o Identified and developed Advocates/Key Opinion Leaders (KOL) physicians and managed to generate Increased Referrals from physicians to surgeons.o Redesigned a patient pathway to include BKP procedure with the spinal surgeons and referring MSL clinicians across several specialist centres across the North of England.

• 

  Prostrakan /Kyowa Hakko Kirin

  Sept 2010 - Feb 2016

  Business Development Manager

  o Market Access Activity - Achieved unprecedented Audit and D&T Approval for Sancuso CINV agent in Sept 2013 at The Christie, National Oncology Centre of Excellence. o Strategic KAM Approach – Mitomycin-C (MMC) / COMBAT (Hyperthermic MMC administration machine) - Mapped out priorities, strategy, and tactics of key accounts and secured X2 HIVEC II trial centre and X6 COMBAT placement accounts within 10 weeks

• 

  Delcath Systems, Inc

  Feb 2016 - Jul 2019

  o Set up a complex service in Cath Lab within strategic specialist hospitals and achieved unprecedented commercial sales with YOY growth 171% in 2018 and 164% in 2017 leading to annual sales of just under $1million revenue in 2018 from private hospitals within the UKo Led on Therapy Development in Ultra Rare Cancer through the refinement of the national patient pathway and building up of an Ad board Expert Panel Consensus Statement in 2018 for submission to NICE IPAC for review of IPG488o Generate referral from across the US and EMEA network for clinicians for referring into specialist hospitals for MDT assessment and approval for treatment at specialist private hospitals. Show less

  • Medical Science Liaison Manager

    Jan 2019 - Jul 2019

  • Country Manager

    Feb 2016 - Dec 2018
• 

  Sequana Medical NV

  Aug 2019 - Jul 2020

  Market Access & Reimbursement Manager

  o Mapped out, navigated 6 Market Access routes to select 2 Optimum Entry Routes, and tested the most feasible route to securing national Reimbursement. o Developed market access and reimbursement strategy and built tactical plans around aligning the cross-functional teams' input and clinical and payer engagement from scratch

• 

  Delcath Systems

  Jun 2021 - now

  Development and implementation of commercial strategy across Europe.

  • General Manager EMEA Interventional Oncology

    Nov 2022 - now

  • Country Manager UK and Ireland

    Jun 2021 - Nov 2022